145 related articles for article (PubMed ID: 6861434)
1. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
Drayer DE; Lorenzo B; Werns S; Reidenberg MM
Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
[TBL] [Abstract][Full Text] [Related]
2. Chromatographic determination of free lidocaine and its active metabolites in plasma from patients under epidural anesthesia.
Kakiuchi Y; Fukuda T; Miyabe M; Homma M; Toyooka H; Kohda Y
Int J Clin Pharmacol Ther; 2002 Nov; 40(11):493-8. PubMed ID: 12698986
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses.
Dickey EJ; McKenzie HC; Brown KA; de Solis CN
Equine Vet J; 2008 Jun; 40(4):348-52. PubMed ID: 18267881
[TBL] [Abstract][Full Text] [Related]
5. Maternal, fetal, and neonatal metabolism of lidocaine.
Kuhnert BR; Knapp DR; Kuhnert PM; Prochaska AL
Clin Pharmacol Ther; 1979 Aug; 26(2):213-20. PubMed ID: 455889
[TBL] [Abstract][Full Text] [Related]
6. Modifications by lidocaine and its N-dealkylated metabolites of the response of the isolated rabbit aorta to transmural electrical stimulation.
Fukuda S; Takeshita H; Toda N
Anesthesiology; 1980 Aug; 53(2):106-12. PubMed ID: 7416521
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of lidocaine in patients with renal failure.
Collinsworth KA; Strong JM; Atkinson AJ; Winkle RA; Perlroth F; Harrison DC
Clin Pharmacol Ther; 1975 Jul; 18(1):59-64. PubMed ID: 1149363
[TBL] [Abstract][Full Text] [Related]
8. Effect of 4% topical lidocaine applied to the face on the serum levels of lidocaine and its metabolite, monoethylglycinexylidide.
Oni G; Brown S; Burrus C; Grant L; Watkins J; Kenkel M; Barton F; Kenkel J
Aesthet Surg J; 2010; 30(6):853-8. PubMed ID: 21131461
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasma alpha1-acid glycoprotein concentration on the accumulation of lidocaine metabolites during continuous epidural anesthesia in infants and children.
Kakiuchi Y; Kohda Y; Miyabe M; Momose Y
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):493-8. PubMed ID: 10543316
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of lidocaine and its principal metabolites during continuous epidural infusion of lidocaine with or without epinephrine.
Kihara S; Miyabe M; Kakiuchi Y; Takahashi S; Fukuda T; Kohda Y; Toyooka H
Reg Anesth Pain Med; 1999; 24(6):529-33. PubMed ID: 10588557
[TBL] [Abstract][Full Text] [Related]
11. Determination of lidocaine and its two N-desethylated metabolites in dog and horse plasma by high-performance liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Maes A; Weiland L; Sandersen C; Gasthuys F; De Backer P; Croubels S
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):180-7. PubMed ID: 17296334
[TBL] [Abstract][Full Text] [Related]
12. [Determination of lidocaine and its metabolites in human plasma by liquid chromatography in combination with tandem mass spectrometry].
Xiang J; Zhang C; Yu Q; Liang MZ; Qin YP; Nan F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):696-9. PubMed ID: 20848799
[TBL] [Abstract][Full Text] [Related]
13. Plasma lidocaine, monoethylglycinexylidide, and glycinexylidide concentrations after epidural administration in geriatric patients.
Fukuda T; Kakiuchi Y; Miyabe M; Okubo N; Yaguchi Y; Kohda Y; Toyooka H
Reg Anesth Pain Med; 2000; 25(3):268-73. PubMed ID: 10834781
[TBL] [Abstract][Full Text] [Related]
14. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.
Orlando R; Piccoli P; De Martin S; Padrini R; Palatini P
Br J Clin Pharmacol; 2003 Jan; 55(1):86-93. PubMed ID: 12534644
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
[TBL] [Abstract][Full Text] [Related]
16. Saliva concentrations of lidocaine and its metabolites in man.
Barchowsky A; Stargel WW; Shand DG; Routledge PA
Ther Drug Monit; 1982; 4(4):335-9. PubMed ID: 7157457
[TBL] [Abstract][Full Text] [Related]
17. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
[TBL] [Abstract][Full Text] [Related]
18. An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.
Pang KS; Terrell JA; Nelson SD; Feuer KF; Clements MJ; Endrenyi L
J Pharmacokinet Biopharm; 1986 Apr; 14(2):107-30. PubMed ID: 3746635
[TBL] [Abstract][Full Text] [Related]
19. Lidocaine metabolite formation as a measure of perioperative liver function.
Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute and chronic moderate hypoxia on the kinetics of lidocaine and its metabolites and on regional blood flow.
du Souich P; Saunier C; Hartemann D; Allam M
Pulm Pharmacol; 1992; 5(1):9-16. PubMed ID: 1591467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
